首页> 美国卫生研究院文献>Molecular Cellular Proteomics : MCP >In Situ Proteomic Analysis of Human Breast Cancer Epithelial Cells Using Laser Capture Microdissection: Annotation by Protein Set Enrichment Analysis and Gene Ontology
【2h】

In Situ Proteomic Analysis of Human Breast Cancer Epithelial Cells Using Laser Capture Microdissection: Annotation by Protein Set Enrichment Analysis and Gene Ontology

机译:使用激光捕获显微切割技术对人乳腺癌上皮细胞进行原位蛋白质组学分析:通过蛋白质集富集分析和基因本体论进行注释

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Identification of molecular signatures that allow detection of the transition from normal breast epithelial cells to malignant invasive cells is a critical component in the development of diagnostic, therapeutic, and preventative strategies for human breast cancer. Substantial efforts have been devoted to deciphering breast cancer etiology at the genome level, but only a limited number of studies have appeared at the proteome level. In this work, we compared individual in situ proteome profiles of nonpatient matched nine noncancerous, normal breast epithelial (NBE) samples with nine estrogen receptor (ER)-positive (luminal subtype), invasive malignant breast epithelial (MBE) samples by combining laser capture microdissection (LCM) and quantitative shotgun proteomics. A total of 12,970 unique peptides were identified from the 18 samples, and 1623 proteins were selected for quantitative analysis using spectral index (SpI) as a measure of protein abundance. A total of 298 proteins were differentially expressed between NBE and MBE at 95% confidence level, and this differential expression correlated well with immunohistochemistry (IHC) results reported in the Human Protein Atlas (HPA) database. To assess pathway level patterns in the observed expression changes, we developed protein set enrichment analysis (PSEA), a modification of a well-known approach in gene expression analysis, Gene Set Enrichment Analysis (GSEA). Unlike single gene-based functional term enrichment analyses that only examines pathway overrepresentation of proteins above a given significance threshold, PSEA applies a weighted running sum statistic to the entire expression data to discover significantly enriched protein groups. Application of PSEA to the expression data in this study revealed not only well-known ER-dependent and cellular morphology-dependent protein abundance changes, but also significant alterations of downstream targets for multiple transcription factors (TFs), suggesting a role for specific gene regulatory pathways in breast tumorigenesis. A parallel GOMiner analysis revealed both confirmatory and complementary data to PSEA. The combination of the two annotation approaches yielded extensive biological feature mapping for in depth analysis of the quantitative proteomic data.
机译:鉴定可检测从正常乳腺上皮细胞向恶性侵袭性细胞转变的分子标记是开发人类乳腺癌诊断,治疗和预防策略的关键组成部分。人们已经在基因组水平上进行了大量的努力来破译乳腺癌的病因学,但是在蛋白质组学水平上仅进行了有限的研究。在这项工作中,我们通过结合激光捕获比较了非患者匹配的九个非癌性,正常乳腺上皮(NBE)样本与九个雌激素受体(ER)阳性(腔亚型),浸润性恶性乳腺上皮(MBE)样本的个体原位蛋白质组谱显微解剖(LCM)和定量shot弹枪蛋白质组学。从18个样品中鉴定出总共12,970个独特的肽段,并选择1623个蛋白进行定量分析,使用光谱指数(SpI)作为衡量蛋白丰度的方法。 NBE和MBE之间总共有298种蛋白质以95%的置信水平差异表达,这种差异表达与人蛋白质图谱(HPA)数据库中报告的免疫组化(IHC)结果密切相关。为了评估观察到的表达变化中的途径水平模式,我们开发了蛋白质集富集分析(PSEA),这是对基因表达分析中著名方法基因集富集分析(GSEA)的修改。不同于仅检查超过给定显着性阈值的蛋白质的途径过度表达的基于单个基因的功能性术语富集分析,PSEA对整个表达数据应用加权的运行总和统计量以发现显着富集的蛋白质组。将PSEA应用于本研究中的表达数据不仅揭示了众所周知的ER依赖和细胞形态依赖的蛋白质丰度变化,而且还显着改变了多个转录因子(TFs)下游靶标的变化,这暗示了特定基因调控的作用乳腺肿瘤发生的途径。平行的GOMiner分析显示PSEA的确证数据和补充数据。两种注释方法的结合产生了广泛的生物学特征图谱,可用于对蛋白质组学定量数据进行深度分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号